ClinicalTrials.gov
public full text
Public Domain
Calcifediol in the Treatment of COVID 19
Patients hospitalized with COVID-19 treated with calcifediol during the first outbreaks of the pandemic (until the first vaccinations) are compared with the aim of determining the therapeutic, clinical, functional, and biochemical variables that modify the response (admission to ICU or death) to calcifediol during hospitalization for COVID 19
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients#979226
- Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support#888177
- Virus-virus Interactions Among Patients Admitted to the Hospices Civils de Lyon, During 2022 to 2025 Winters Seasons#1140744
- Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.#1072226
- Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms#1086700
Record · ID 1101278
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive